Interestingly, elevated hepcidin levels have been reported in patients with type 2 diabetes in the presence of chronic renal disease, obesity or inflammation56,57, which could explain the observed reduction in ferroportin intensity. This evidence concerns the gene HAMP and obesity due to melanocortin 4 receptor deficiency.